English
|
Spanish
Supporting oncology professionals through education
Login
Register
The content on this site is intended for healthcare professionals only
Menu
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Latest news
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Journal information
Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us
Author information
Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us
Reviewer information
Reviewer guidelines
Memberships
Videos
Recent videos
Sign up
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Conferences
Latest conferences
Sign up for latest coverage
Submit your event
About
e
cancer
About
e
cancer
Our founders
Funding statement
Contact us
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
Prince of Wales Hospital, Australia
Share :
ESMO 33
12 - 16 Sep 2008
Please rate this video
The information in this video was of interest to me
The information in this video is likely to improve my clinical practice or research
I would recommend this video to my colleagues
Published:
3 Dec 2008
Views:
18302
Rating:
Save
Rate video
Prof. Michael Friedlander
Investigational drug shows promise in ovarian cancer.
Categories:
Ovary & gynaecology
Drug development
Related Videos
Choosing Wisely in endometrial & cervix cancers: Medical therapy
Dr Jaya Ghosh - Tata Memorial Hospital, Mumbai, India
22 Sep 2024
Mirvetuximab soravtansine and pembrolizumab combo shows promise in endometrial...
Dr Rebecca Porter - Dana-Farber Cancer Institute, Boston, USA
12 Apr 2024
The treatment of cervical cancer in the presence of HIV in Sub-Saharan Africa
Dr Ntokozo Ndlovu - University of Zimbabwe, Harare, Zimbabwe
9 Jan 2024
Low-dose olanzapine after highly emetogenic chemotherapy can be the new...
Dr Jyoti Bajpai - Tata Memorial Centre, Mumbai, India
7 Dec 2023
First-line chemotherapy with atezolizumab and bevacizumab significantly...
Dr Ana Oaknin - Vall d´Hebron Institute of Oncology, Barcelona, Spain
4 Dec 2023
Atezolizumab with platinum-based CT and niraparib show no improvement in...
Dr Antonio Gonzalez Martin - Cancer Center Clínica Universidad de Navarra...
31 Oct 2023
Induction chemotherapy added to chemoradiation improves PFS and OS in advanced...
Dr Mary McCormack - University College Hospital, London, UK
23 Oct 2023
OncoAlert round up July 28th to August 3rd, 2023
Dr Gil Morgan - Executive Director, OncoAlert
4 Aug 2023
Gynaecological cancer: New targets and immunotherapy developments
Dr Mark Shahin - Jefferson Health, Philadelphia, USA
7 Jul 2023
More from
e
cancer